CDK6 and diabetic kidney disease: Silencing miR-21 protects animal models from DKD [113] as its overexpression is associated with mesangial cell hypertrophy by regulating Cdc25a and Cdk6, podocyte damage, and ECM accumulation by targeting Pten [113].